EFPIA - NEWSLETTER

EFPIA Newsletter 06 November 2025

News

31 October 2025 Healthcare Associations warn of risks from PFAS restriction approach - failure to assess the...

Healthcare Associations warn that ECHA’s proposed PFAS restriction fails to assess the specific impacts on the healthcare...

Blogs

04 November 2025 From guidance to implementation: EFPIA’s reflections on EU HTA scoping & PICO exercises

As the EU launches its first JCA, EFPIA shares reflections on the new HTA scoping guidance and PICO exercises

04 November 2025 How can companies manage reputational risks in a changing world?

From fraud and cybercrime to compliance and data protection, life sciences firms must monitor risks to avoid being blindsided...

Celebrating 10 Years of #MedSafetyWeek

Monday, 3 November marked the start of #MedSafetyWeek 2025!

We’re proud to join forces with medicines regulatory authorities and partners from 118 countries worldwide to encourage the reporting of suspected side effects from medicines.

Medicines are continuously monitored to ensure their safety and reports form an essential part of global pharmacovigilance systems. These reports help regulatory agencies and pharmaceutical companies assess the safety of medicines after they have been placed on the market and throughout the product life cycle, improving patient safety worldwide.

We can all help make medicines safer. Learn more about the campaign here.

Events

17 NOV 2025

Healthcare Systems in the Face of Climate Change Brussels

The DULBEA, in partnership with Solidaris, is pleased to invite you to its upcoming International Conference on the...

Learn more →

18 NOV 2025

POLITICO Health Care Summit 2025 Brussels, Belgium

Join us on 18 November during the POLITICO Health Care Summit for the Fireside Chat | Unleashing the Future of Life...

Learn more →

01 DEC 2025

“Europe’s Beating Cancer Plan in Action: National Implementation for the Future”... Online

The EFPIA Oncology Platform and Cancer Patients Europe are delighted to invite you to the launch webinar of their new...

Learn more →

04 DEC 2025

Future-proofing Alzheimer’s care: scaling innovation for a healthier Europe Online

Explore how new therapies and scalable solutions can transform care pathways and strengthen health systems.

Learn more →

What we are reading

ACT EU "Trial Map" now available in all official EU languages 31 October 2025 (EMA)

Can AI help beat vaccine misinformation? We interviewed ChatGPT 31 October 2025 (Vaccines Today)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶